NEW YORK (360Dx) – Molecular diagnostics company iCubate today announced the US Food and Drug Administration has cleared its iC-System and iC-GPC assay for the rapid detection of pathogenic bacteria associated with bloodstream infections.
To read the full story....
Register for Free....and receive Daily News bulletins.
Already have an account?
Login Now.